Related Experiment Video
Updated: Sep 30, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Therapy of chronic hepatitis B infection]
1Abteilung Gastroenterologie Hepatologie & Endokrinologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover.
Abstract:
Around 350 million people worldwide are chronically infected with the hepatitis B virus. In adults around 5% and during perinatal contact around 100% of the infections become chronic. The main complications of chronic HBV infection are liver cirrhosis and hepatocellular carcinoma. Therefore after chronic HBV infection has been diagnosed early therapy has to be considered. At present two drugs are available: Interferon-alpha and lamivudine. Therapy with Interferon-alpha is successful in 30-40% of the patients. In contrast, the initial response rate during lamivudine therapy is very good. However, in many of the patients mutant HBV strains are selected. Therefore in each patient it has to be considered individually which of the two drugs should be used. In this review these questions will be addressed and a special focus will be the use of lamivudine. Additionally future treatment options will be discussed.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inhibitors of Viral Protein Synthesis
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
